Acknowledging the kind of traction gained by this market, recently published a study report asserts the Atropine Market is expected to reach USD 2247.5 million by 2027, registering a phenomenal CAGR of 1.8% during the review period (2022 to 2027)
Atropine Market Overview
Atropine is a medication that is used to treat nerve agents and pesticide poisonings. It is also used to treat certain types of slow heart rate and to reduce saliva flow during surgery. It is typically given intravenously or as a muscle injection. This medication is also available as eye drops to treat uveitis and early amblyopia. Intravenous solutions typically begin working within a minute and last for 30 to 60 minutes.
Surgical services are widely recognized as an essential component of the public health system. Surgical services are in high demand in both developed and developing countries, as illness patterns change at a rapid pace. Surgery is expected to play a larger role in public health as a result of the epidemiological shift. The rising number of fatalities and major surgical procedures is expected to drive up demand for atropine. Furthermore, the emergence of robotics, telemedicine, and digital medical records will drive the global atropine market in the near future.As the pharmaceutical industry expands, key players in the atropine market are expected to gain new growth opportunities. The atropine industry is expected to grow in the coming years as the world's population ages. Furthermore, rising investments by well-known corporations are expected to propel the atropine market in the near future.
Who are the Major Players in the Atropine Market?
The global Atropine includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, Wuhan senwayer century and others.
Industry News and Updates:
November 8, 2021: C2 PHARMA COMPLETES MULTIPLE LOCAL REGULATORY FILINGS AND EXPANDS PORTFOLIO
C2 PHARMA, a pharmaceutical group established in 2014, focused on niche active pharmaceutical ingredients (APIs), has expanded the API product portfolio. Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Korea, Brazil, and Mexico.
2021-07-21: CR Double-Crane and NOVITA signed an exclusive license agreement on the development, production and commercialization of NP-G2-044
CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane), a subsidiary of China Resources Pharmaceutical Group Limited (Stock Code: 3320.HK), obtained exclusive authorization from U.S. company Novita Pharmaceuticals, Inc. for the development, production and commercialization, as well as the intellectual property right of NP-G2-044 Fascin inhibitor, a new target medicine, in Greater China
What are the major Applications, Types, and Regions for the Atropine Market?
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
- Gastrointestinal
- Ophthalmology
- Other
Atropine Market Regional Analysis
Over the forecast period, the Asia Pacific atropine market is expected to grow at the fastest rate. The healthcare sector in this region is rapidly expanding as a result of increased private and government investment and a high demand for better access to healthcare services. Furthermore, ongoing technological advancements such as digital medical records, telemedicine, and robot nurses would contribute to the growth of the atropine market in this region. As a result of these advanced technologies, hospitals and medical facilities have evolved. As a result, there is an increase in demand for pharmaceutical products and healthcare services in this region. Furthermore, governments in developing countries such as India and China are investing heavily in the advancement of the healthcare industry.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
The Atropine Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Atropine Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Atropine Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 1.8% over the forecast period (2022-2027)
|
By Type
|
|
By Application
|
- Gastrointestinal
- Ophthalmology
- Other
|
By Companies
|
C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, Wuhan senwayer century
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
121
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Atropine Report
- Evaluate Atropine market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and different industries verticals.
- Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.
- Get in-depth insights on your competitor’s performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.
- Analyze the sales and distribution channels across geographies to enhance top-line revenues.
- Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies to your processes.
- Get a quick outlook on the Atropine market entropy – M&As, deals, partnerships, and product launches of all key players for the past 5 years.
- Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.
Frequently Asked Questions
What is the study period of this market?
The Atropine Market is studied from 2022 - 2027.
What is the growth rate of the Atropine Market?
The Atropine Market is growing at a CAGR of 1.8% over the next 5 years.
Who are the key players in Atropine Market?
C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International, SAURAV CHEMICALS, Katsura Chemical, Hangzhou Vega, Wuhan senwayer century
What regions does this Atropine Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Atropine Market?
Injection, Drop, Gel
What are the major end-use applications of Atropine Market?
Gastrointestinal, Ophthalmology, Other
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
